|
1
|
Avgustinova A and Benitah SA: The
epigenetics of tumour initiation: Cancer stem cells and their
chromatin. Curr Opin Genet Dev. 36:8–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miremadi A, Oestergaard MZ, Pharoah PD and
Caldas C: Cancer genetics of epigenetic genes. Hum Mol Genet.
16(R1): R28–R49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bird A: DNA methylation patterns and
epigenetic memory. Genes Dev. 16:6–21. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jovanovic J, Rønneberg JA, Tost J and
Kristensen V: The epigenetics of breast cancer. Mol Oncol.
4:242–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
6
|
Qiu X, Hother C, Ralfkiær UM, Søgaard A,
Lu Q, Workman CT, Liang G, Jones PA and Grønbæk K: Equitoxic doses
of 5-azacytidine and 5-aza-2′deoxycytidine induce diverse immediate
and overlapping heritable changes in the transcriptome. PLoS One.
5:e129942010. View Article : Google Scholar
|
|
7
|
Snyder RD and Lachmann PJ: Differential
effects of 5-azacyti-dine and 5-azadeoxycytidine on cytotoxicity,
DNA-strand breaking and repair of X-ray-induced DNA damage in HeLa
cells. Mutat Res. 226:185–190. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z, Lu H, Liu R, Chen B, Wang S, Ma J
and Fu J: The dineolignan from Saururus chinensis, manassantin B,
inhibits tumor-induced angiogenesis via downregulation of matrix
metalloproteinases 9 in human endothelial cells. Oncol Rep.
32:659–667. 2014.PubMed/NCBI
|
|
9
|
Kumta SM, Huang L, Cheng YY, Chow LT, Lee
KM and Zheng MH: Expression of VEGF and MMP-9 in giant cell tumor
of bone and other osteolytic lesions. Life Sci. 73:1427–1436. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sato H and Seiki M: Regulatory mechanism
of 92 kDa type IV collagenase gene expression which is associated
with invasiveness of tumor cells. Oncogene. 8:395–405.
1993.PubMed/NCBI
|
|
11
|
Iyer V, Pumiglia K and DiPersio CM:
Alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized
keratinocytes: A novel mechanism of integrin-mediated MMP gene
expression. J Cell Sci. 118:1185–1195. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramos-DeSimone N, Hahn-Dantona E, Sipley
J, Nagase H, French DL and Quigley JP: Activation of matrix
metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1
cascade enhances tumor cell invasion. J Biol Chem. 274:13066–13076.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watanabe H, Nakanishi I, Yamashita K,
Hayakawa T and Okada Y: Matrix metalloproteinase-9 (92 kDa
gelatinase/type IV collagenase) from U937 monoblastoid cells:
Correlation with cellular invasion. J Cell Sci. 104:991–999.
1993.PubMed/NCBI
|
|
14
|
Lyons JG, Birkedal-Hansen B, Pierson MC,
Whitelock JM and Birkedal-Hansen H: Interleukin-1 beta and
transforming growth factor-alpha/epidermal growth factor induce
expression of M(r) 95,000 type IV collagenase/gelatinase and
interstitial fibroblast-type collagenase by rat mucosal
keratinocytes. J Biol Chem. 268:19143–19151. 1993.PubMed/NCBI
|
|
15
|
Ito M, Hagiyama M, Mimae T, Inoue T, Kato
T, Yoneshige A, Nakanishi J, Kondo T, Okada M and Ito A: α-Parvin,
a pseudopodial constituent, promotes cell motility and is
associated with lymph node metastasis of lobular breast carcinoma.
Breast Cancer Res Treat. 144:59–69. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang D, Lu P, Zhang H, Luo M, Zhang X, Wei
X, Gao J, Zhao Z and Liu C: Oct-4 and Nanog promote the
epithelial-mesenchymal transition of breast cancer stem cells and
are associated with poor prognosis in breast cancer patients.
Oncotarget. 5:10803–10815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu SM and Kim SJ: Production of reactive
oxygen species by withaferin A causes loss of type collagen
expression and COX-2 expression through the PI3K/Akt, p38, and JNK
pathways in rabbit articular chondrocytes. Exp Cell Res.
319:2822–2834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu SM and Kim SJ: DNA-hypomethylating
agent, 5′-azacytidine, induces cyclooxygenase-2 expression via the
PI3-kinase/Akt and extracellular signal-regulated kinase-1/2
pathways in human HT1080 fibrosarcoma cells. Int J Oncol.
47:1469–1475. 2015.PubMed/NCBI
|
|
19
|
Yoshihara Y, Nakamura H, Obata K, Yamada
H, Hayakawa T, Fujikawa K and Okada Y: Matrix metalloproteinases
and tissue inhibitors of metalloproteinases in synovial fluids from
patients with rheumatoid arthritis or osteoarthritis. Ann Rheum
Dis. 59:455–461. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Spinale FG, Coker ML, Krombach SR,
Mukherjee R, Hallak H, Houck WV, Clair MJ, Kribbs SB, Johnson LL,
Peterson JT, et al: Matrix metalloproteinase inhibition during the
development of congestive heart failure: Effects on left
ventricular dimensions and function. Circ Res. 85:364–376. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stricklin GP and Welgus HG: Human skin
fibroblast collagenase inhibitor. Purification and biochemical
characterization. J Biol Chem. 258:12252–12258. 1983.PubMed/NCBI
|
|
22
|
Gueders MM, Foidart JM, Noel A and Cataldo
DD: Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs
in the respiratory tract: Potential implications in asthma and
other lung diseases. Eur J Pharmacol. 533:133–144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Offersen BV, Pfeiffer P, Andreasen P and
Overgaard J: Urokinase plasminogen activator and plasminogen
activator inhibitor type-1 in non small-cell lung cancer: Relation
to prognosis and angiogenesis. Lung Cancer. 56:43–50. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Z and Zhang R: Epigenetics in
autoimmune diseases: Pathogenesis and prospects for therapy.
Autoimmun Rev. 14:854–863. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rodriguez J, Frigola J, Vendrell E,
Risques RA, Fraga MF, Morales C, Moreno V, Esteller M, Capellà G,
Ribas M, et al: Chromosomal instability correlates with genome-wide
DNA demethylation in human primary colorectal cancers. Cancer Res.
66:8462–9468. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoo CB and Jones PA: Epigenetic therapy of
cancer: Past, present and future. Nat Rev Drug Discov. 5:37–50.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Constantinides PG, Jones PA and Gevers W:
Functional striated muscle cells from non-myoblast precursors
following 5-azacytidine treatment. Nature. 267:364–366. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alexander VM, Roy M, Steffens KA,
Kunnimalaiyaan M and Chen H: Azacytidine induces cell cycle arrest
and suppression of neuroendocrine markers in carcinoids. Int J Clin
Exp Med. 3:95–102. 2010.PubMed/NCBI
|
|
30
|
Wu Y, Meng L, Wang H, Xu Q, Wang S, Wu S,
Xi L, Zhao Y, Zhou J, Xu G, et al: Regulation of DNA methylation on
the expression of the FHIT gene contributes to cervical carcinoma
cell tumorigenesis. Oncol Rep. 16:625–629. 2006.PubMed/NCBI
|
|
31
|
Bernal T, Moncada-Pazos A, Soria-Valles C
and Gutiérrez-Fernández A: Effects of azacitidine on matrix
metalloproteinase-9 in acute myeloid leukemia and myelodysplasia.
Exp Hematol. 41:172–179. 2013. View Article : Google Scholar
|
|
32
|
Sato N, Maehara N, Su GH and Goggins M:
Effects of 5-aza-2′-deoxycytidine on matrix metalloproteinase
expression and pancreatic cancer cell invasiveness. J Natl Cancer
Inst. 95:327–330. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim HS, Luo L, Pflugfelder SC and Li DQ:
Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK
pathways in human corneal epithelial cells. Invest Ophthalmol Vis
Sci. 46:840–848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chia-Lan T, Chen WC, Hsieh HL, Chi PL,
Hsiao LD and Yang CM: Erratum to: TNF-alpha induces MMP-9
expression and soluble ICAM-1 release via TRAF2, c-src, MAPKs and
NF-kappaB in osteoblast-like MC3T3-E1 cells. J Biomed Sci.
22:202015. View Article : Google Scholar
|
|
36
|
Liang KC, Lee CW, Lin WN, Lin CC, Wu CB,
Luo SF and Yang CM: Interleukin-1beta induces MMP-9 expression via
p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling
pathways in human tracheal smooth muscle cells. J Cell Physiol.
211:759–770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Reddy KB, Krueger JS, Kondapaka SB and
Diglio CA: Mitogen-activated protein kinase (MAPK) regulates the
expression of progelatinase B (MMP-9) in breast epithelial cells.
Int J Cancer. 82:268–273. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saika S, Okada Y, Miyamoto T, Yamanaka O,
Ohnishi Y, Ooshima A, Liu CY, Weng D and Kao WW: Role of p38 MAP
kinase in regulation of cell migration and proliferation in healing
corneal epithelium. Invest Ophthalmol Vis Sci. 45:100–109. 2004.
View Article : Google Scholar
|
|
39
|
Lu Y, Fukuda K, Liu Y, Kumagai N and
Nishida T: Dexamethasone inhibition of IL-1-induced collagen
degradation by corneal fibro-blasts in three-dimensional culture.
Invest Ophthalmol Vis Sci. 45:2998–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wymann MP and Pirola L: Structure and
function of phosphoinositide 3-kinases. Biochim Biophys Acta.
1436:127–150. 1998. View Article : Google Scholar : PubMed/NCBI
|
